MedTrace Logo

Bupivacaine Epiphora Trial

NCT03266081 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2022-08-25

No results posted yet for this study

Summary

The objective of this study is to investigate quantitative improvement in excessive tearing after administration of Bupivacaine, a local anesthetic, into the affected eyelids.

Conditions

  • Epiphora
  • Ptosis

Interventions

DRUG

0.75% bupivacaine

topical anesthetic

Sponsors & Collaborators

Principal Investigators

  • Albert Y Wu, MD PhD · Icahn School of Medicine at Mount Sinai

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2022-08-23
Completion
2022-08-23
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03266081 on ClinicalTrials.gov